ACAD
30.37
-0.83
-2.66%
AEMD
0.21
-0.02
-6.67%
APRI
1.925
-0.005
-0.259%
ARNA
4.34
-0.02
-0.46%
ATEC
1.4
-0.04
-2.78%
CNAT
6.76
+1
+17.36%
CRXM
0.193
+0.00
+0.05714%
CYTX
1.18
-0.01
-0.84%
DXCM
58.37
-1.4
-2.34%
GNMK
13.09
+0.04
+0.31%
HALO
13.31
+0.02
+0.15%
ILMN
184.37
+1.09
+0.59%
INNV
0.149
-0.026
-14.6857%
INO
8.09
-0.1
-1.22%
ISCO
0.058
+0.00
+0.7005%
ISIS
61.15
-1.24
-1.99%
LGND
70.3
-0.4
-0.57%
LPTN
2.52
0.00
0.00%
MBVX
1.75
-0.32
-15.46%
MEIP
1.83
-0.07
-3.68%
MNOV
3.32
+0.04
+1.22%
MRTX
26.37
+0.65
+2.53%
MSTX
0.52
0.00
-0.19%
NBIX
37.33
+0.96
+2.64%
NUVA
43.98
-0.15
-0.34%
ONCS
0.339
-0.004
-1.0234%
ONVO
3.93
-0.1
-2.48%
OREX
7.25
+0.33
+4.77%
OTIC
33.76
+1.3
+4.00%
QDEL
26.52
-0.38
-1.41%
RCPT
138.99
+0.48
+0.35%
RGLS
16.56
+0.04
+0.24%
RMD
70.25
-0.13
-0.18%
SCIE
0.031
-0.004
-11.429%
SPHS
0.54
-0.02
-3.57%
SRNE
11.85
+0.07
+0.59%
TROV
6.77
+0.12
+1.80%
VICL
0.855
-0.009
-1.042%
VOLC
17.99
0.00
0.00%
ZGNX
1.31
+0.01
+0.77%
ACAD
30.37
-0.83
-2.66%
AEMD
0.21
-0.02
-6.67%
APRI
1.925
-0.005
-0.259%
ARNA
4.34
-0.02
-0.46%
ATEC
1.4
-0.04
-2.78%
CNAT
6.76
+1
+17.36%
CRXM
0.193
+0.00
+0.05714%
CYTX
1.18
-0.01
-0.84%
DXCM
58.37
-1.4
-2.34%
GNMK
13.09
+0.04
+0.31%
HALO
13.31
+0.02
+0.15%
ILMN
184.37
+1.09
+0.59%
INNV
0.149
-0.026
-14.6857%
INO
8.09
-0.1
-1.22%
ISCO
0.058
+0.00
+0.7005%
ISIS
61.15
-1.24
-1.99%
LGND
70.3
-0.4
-0.57%
LPTN
2.52
0.00
0.00%
MBVX
1.75
-0.32
-15.46%
MEIP
1.83
-0.07
-3.68%
MNOV
3.32
+0.04
+1.22%
MRTX
26.37
+0.65
+2.53%
MSTX
0.52
0.00
-0.19%
NBIX
37.33
+0.96
+2.64%
NUVA
43.98
-0.15
-0.34%
ONCS
0.339
-0.004
-1.0234%
ONVO
3.93
-0.1
-2.48%
OREX
7.25
+0.33
+4.77%
OTIC
33.76
+1.3
+4.00%
QDEL
26.52
-0.38
-1.41%
RCPT
138.99
+0.48
+0.35%
RGLS
16.56
+0.04
+0.24%
RMD
70.25
-0.13
-0.18%
SCIE
0.031
-0.004
-11.429%
SPHS
0.54
-0.02
-3.57%
SRNE
11.85
+0.07
+0.59%
TROV
6.77
+0.12
+1.80%
VICL
0.855
-0.009
-1.042%
VOLC
17.99
0.00
0.00%
ZGNX
1.31
+0.01
+0.77%
Home » Archive by Category

Xconomy

West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More

November 20, 2014 – 2:21 pm

Snow? What snow? The only thing piling up at astonishing rates on the West Coast this week is biotech news. Up in Seattle, the Fred Hutchinson Cancer Research Center has unveiled its new president,…

[[Click headline to continue reading.]]

Breaking Bottlenecks, Opening the Floodgates to Genomic Data

November 18, 2014 – 4:00 am

There is a major transformational step underway for managing the growing amount of human genomic data. To date, the focus has been on amassing databanks of genomes and then developing new tools to…

[[Click headline to continue reading.]]

New Study Shows How ZMapp Binds to Ebola, Ways to Boost Potency

November 17, 2014 – 2:18 pm

Scientists at The Scripps Research Institute have produced the first 3-D image of how the ZMapp drug developed by San Diego’s Mapp Biopharmaceutical binds to the Ebola virus, providing new insights…
[[Click headline to continue reading.]]

New Research Could (Finally) Remove RNAi’s Commercial Limitations

November 17, 2014 – 9:05 am

[Corrected 11/17/14, 12:30pm. See below.] If nothing else, the acronym RNAi, which stands for ribonucleic acid interference, should be familiar to biotech observers as something that won two…

[[Click headline to continue reading.]]

Device Maker Says Ebola Patient Recovered After Blood Filtration

November 14, 2014 – 9:10 am

As the global death toll from the current Ebola outbreak officially hit 5,147 this week, a San Diego medical device company is reporting promising findings in the treatment of one infected patient….

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More

November 13, 2014 – 12:16 pm

[Corrected 11/13/14, 5:40 pm. See below.] West Coast spotlights this week are on new ways to fight disease. Some are close to getting to market: Amgen announced late-stage development and regulatory…

[[Click headline to continue reading.]]

With Wires and Electrodes, Tara Bio Builds a Heart on a Chip

November 12, 2014 – 4:28 am

It’s been pretty clear for some time that there’s a big need to improve the efficiency of drug R&D. By industry’s count, drugs cost over $1 billion to develop, and most of them fail. A big…
[[Click headline to continue reading.]]

Lowering the Cost of Failure in Biopharmaceuticals

November 11, 2014 – 1:00 am

In any business, projects fail, but in biopharmaceuticals, the consequences of failure are especially damaging. Projects in the industry tend to be long and expensive—from clinical trials to…
[[Click headline to continue reading.]]

DMI Diagnostic Device Wins Grand Prize in Nokia Sensing XPrize

November 10, 2014 – 7:00 am

The XPrize Foundation returned to San Diego today to announce that a team led by Eugene Y. Chan of the DNA Medicine Institute (DMI) in Cambridge, MA, is the winner of the second $525,000 grand prize…

[[Click headline to continue reading.]]

Beg, Borrow, or Steal: Accessing Unaffordable Science Journals

November 10, 2014 – 1:00 am

If you work in academia or in Big Pharma, you likely have easy access to the world’s scientific literature. Outside of these places, however, obtaining affordable access to the latest scientific…
[[Click headline to continue reading.]]